| Title | Expert Opinion on Investigational Drugs |
| Abbreviation | Expert Opin. Investig. Drugs |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1) |
| h-index | 117 |
| Overall Rank/Ranking | 2496 |
| SCImago Journal Rank (SJR) | 1.414 |
| Impact Score | 4.77 |
| Publisher | Taylor and Francis Ltd. |
| Country | United Kingdom |
| ISSN | 13543784, 17447658 |
| Best Quartile | Q1 |
| Coverage History | 1994-2023 |
Expert Opinion on Investigational Drugs ranks #39 of 216 in the Pharmacology & Pharmacy category in the 2008 ISI Journal Citation Reports.
Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development.
Expert Opinion on Investigational Drugs is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1). It is published by Taylor and Francis Ltd.. The overall rank of Expert Opinion on Investigational Drugs is 2496. According to SCImago Journal Rank (SJR), this journal is ranked 1.414. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 117. The best quartile for this journal is Q1.
The ISSN of Expert Opinion on Investigational Drugs journal is 13543784, 17447658. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Opinion on Investigational Drugs is cited by a total of 1698 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Expert Opinion on Investigational Drugs is 4.77, which is computed in 2024 as per its definition. Expert Opinion on Investigational Drugs IF is decreased by a factor of 0.21 and approximate percentage change is -4.22% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Expert Opinion on Investigational Drugs is 4.77. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.77 |
| 2022 | 4.98 |
| 2021 | 5.25 |
| 2020 | 4.97 |
| 2019 | 4.61 |
| 2018 | 3.61 |
| 2017 | 3.58 |
| 2016 | 3.80 |
| 2015 | 3.84 |
| 2014 | 4.18 |
Expert Opinion on Investigational Drugs has an h-index of 117. It means 117 articles of this journal have more than 117 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Expert Opinion on Investigational Drugs is 13543784, 17447658. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Expert Opinion on Investigational Drugs is 2496. According to SCImago Journal Rank (SJR), this journal is ranked 1.414. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.414 |
| 2022 | 1.290 |
| 2021 | 1.177 |
| 2020 | 1.410 |
| 2019 | 1.180 |
| 2018 | 1.076 |
| 2017 | 1.166 |
| 2016 | 1.210 |
| 2015 | 1.341 |
| 2014 | 1.431 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2496 |
| 2022 | 2756 |
| 2021 | 3158 |
| 2020 | 2517 |
| 2019 | 3346 |
| 2018 | 3900 |
| 2017 | 3486 |
| 2016 | 3318 |
| 2015 | 2866 |
| 2014 | 2495 |
Expert Opinion on Investigational Drugs is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1994-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Expert Opinion on Investigational Drugs is Expert Opin. Investig. Drugs. This abbreviation ('Expert Opin. Investig. Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Expert Opinion on Investigational Drugs latest impact IF is 4.77. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 5.25 (2021) and 3.58 (2017), respectively, in the last 10 years. Moreover, its average IS is 4.36 in the previous 10 years.
The Expert Opinion on Investigational Drugs has an SJR (SCImago Journal Rank) of 1.414, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.431 in 2014 and the lowest being 1.076 in 2018. Furthermore, the average SJR of the Expert Opinion on Investigational Drugs over the previous 10-year period stands at 4.36.
The latest h-index of the Expert Opinion on Investigational Drugs is 117.
The Expert Opinion on Investigational Drugs is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.
The Expert Opinion on Investigational Drugs is currently ranked 2496 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2495 in 2014 and its lowest position of 3900 in 2018.
The standard ISO4 abbreviation for the Expert Opinion on Investigational Drugs is Expert Opin. Investig. Drugs.
Expert Opinion on Investigational Drugs is classified as a journal that the Taylor and Francis Ltd. publishes.
The Expert Opinion on Investigational Drugs encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Expert Opinion on Investigational Drugs is assigned the following International Standard Serial Numbers (ISSN): 13543784, 17447658.
The best quartile for the Expert Opinion on Investigational Drugs is Q1 (2023).
The Expert Opinion on Investigational Drugs coverage history can be summarized as follows: 1994-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9513 | Vilnius Gediminas Technical University | 48 | 3.30 |
| Criminal Justice Review | journal | 12054 | SAGE Publications Inc. | 42 | 1.10 |
| International Journal of Mathematical Education in Science and Technology | journal | 8417 | Taylor and Francis Ltd. | 42 | 1.17 |
| Abacus | journal | 5997 | Wiley-Blackwell Publishing Ltd | 53 | 2.75 |
| Journal of Education and Work | journal | 11494 | Brill Academic Publishers | 45 | 2.17 |
| Studies in Continuing Education | journal | 7550 | Routledge | 40 | 3.04 |
| Educational Measurement: Issues and Practice | journal | 5979 | Wiley-Blackwell Publishing Ltd | 64 | 1.67 |
| Tekstilec | trade journal | 18966 | University of Ljubljana Press | 15 | 0.91 |
| Proceedings of the Technical Association of the Graphic Arts, TAGA | conference and proceedings | 30903 | Technical Association of the Graphic | 8 | 0.00 |
| Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.77 |
| 2022 | 4.98 |
| 2021 | 5.25 |
| 2020 | 4.97 |
| 2019 | 4.61 |
| 2018 | 3.61 |
| 2017 | 3.58 |
| 2016 | 3.80 |
| 2015 | 3.84 |
| 2014 | 4.18 |
